Barclays began coverage on shares of Humana (NYSE:HUM) in a report released on Thursday morning, Marketbeat.com reports. The firm issued an overweight rating and a $370.00 price target on the insurance provider’s stock.
HUM has been the topic of several other reports. Zacks Investment Research lowered Humana from a buy rating to a hold rating in a research note on Friday, May 18th. ValuEngine lowered Humana from a buy rating to a hold rating in a research note on Saturday, June 2nd. BMO Capital Markets upped their price objective on Humana from $328.00 to $355.00 and gave the company an outperform rating in a research note on Monday, June 25th. Piper Jaffray Companies upped their price objective on Humana from $355.00 to $380.00 and gave the company an overweight rating in a research note on Friday, August 24th. Finally, Bank of America upped their price objective on Humana from $338.00 to $375.00 and gave the company a buy rating in a research note on Thursday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $331.11.
HUM stock opened at $337.24 on Thursday. Humana has a 1-year low of $231.90 and a 1-year high of $339.88. The company has a market capitalization of $45.68 billion, a PE ratio of 28.80, a P/E/G ratio of 1.65 and a beta of 0.96. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.59%. Humana’s dividend payout ratio (DPR) is presently 17.08%.
In related news, insider Elizabeth D. Bierbower sold 3,092 shares of the stock in a transaction that occurred on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the sale, the insider now directly owns 14,289 shares in the company, valued at approximately $4,715,370. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Alan Wheatley sold 11,468 shares of the stock in a transaction that occurred on Tuesday, June 19th. The stock was sold at an average price of $299.40, for a total value of $3,433,519.20. Following the sale, the insider now owns 3,889 shares in the company, valued at $1,164,366.60. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,752 shares of company stock worth $16,581,234. 0.60% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Synovus Financial Corp acquired a new position in Humana during the 1st quarter worth $100,000. Sun Life Financial INC lifted its holdings in Humana by 120.7% during the 2nd quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after buying an additional 204 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new position in Humana during the 1st quarter worth $113,000. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in Humana by 2,984.6% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after buying an additional 388 shares in the last quarter. Finally, Stratos Wealth Partners LTD. lifted its holdings in Humana by 448.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 417 shares of the insurance provider’s stock worth $112,000 after buying an additional 341 shares in the last quarter. Institutional investors and hedge funds own 93.00% of the company’s stock.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Read More: Price to Earnings Ratio (PE)
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.